°×С½ãÂÛ̳

On 9^th – 10^th September 2024, °×С½ãÂÛ̳ Medical Physics and Biomedical Engineering was delighted to host the EU-funded, Consortium for their third in-person meeting. The aim of the meeting was to discuss the progress of the past year (the second year of the project) with feedback from the External Advisory Board and to define actions for the near future.

The Consortium also welcomed new PhD students to the project, including from °×С½ãÂÛ̳. 

After the Consortium meeting, the group headed to Birmingham to , where they displayed their poster presentations.

Prof Ilias Tachtsidis, who is the , commented:

"I am very excited to welcome to the department our European HyperProbe partners for our year 2 consortium meeting. Our HyperProbe project is going from strength to strength with several publications describing our unique in house developed hyperspectral imaging instrument; and demonstrating its use in classifying glioblastoma tumour biopsies. We are looking forward for the next three years to move our technologies intraoperative."

About the Project

HyperProbe is constructing a new optical imaging device that will improve brain surgery by providing enhanced information to neurosurgeons during surgery. The HyperProbe device will provide real-time, high spatial resolution brain tissue images. It will resolve brain tissue cellular and molecular biomarkers with high specificity and sensitivity. Furthermore, it will implement AI and ML approaches for data analysis and image reconstruction for a variety of purposes. The HyperProbe device will be a compact instrument allowing surgeons to easily use it, read the data it provides and integrate it with existing instrumentation. This will contribute to enhance patients’ treatments and life expectancy.

The latest publication:

EU-funding

The HyperProbe project receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101071040.The UK participant (°×С½ãÂÛ̳) in the Horizon Europe Project ‘HyperProbe’ is supported by UKRI grant numbers 10048387.

Disclaimer

Funded by the European Union. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.